Newly Diagnosed Meningioma
RADIATION THERAPY VS. OBSERVATION FOR NEWLY DIAGNOSED MENINGIOMA
A Phase 3 randomized trial that studies how well radiation therapy works compared with observation in treating patients with newly diagnosed Meningioma that has been completely removed by surgery.
Learn More
SMO/AKT/ NF2/CDK INHIBITORS FOR PROGRESSIVE MENINGIOMAS
A Phase II open label trial that studies how well vismodegib, focal adhesion kinase (FAK) inhibitor GSK2256098, and Capivasertib work in treating patients with progressive Meningioma.
Learn More